ASX:IMR

Imricor Medical Systems Stock Forecast, Price & News

Add

Compare

Today's Range N/A

50-Day Range N/A

52-Week Range N/A

Volume27,486 shs

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Receive IMR News and Ratings via Email

Sign-up to receive the latest news and ratings for Imricor Medical Systems and its competitors with MarketBeat's FREE daily newsletter.

About Imricor Medical Systems

Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States. The company's principal products include the Advantage-MR EP Recorder/Stimulator system, an electrophysiology amplifier and recording system with integrated cardiac stimulator; Vision-MR Ablation Catheter, which is used as an indication for treating type I atrial flutter; and Vision-MR Dispersive Electrode that is used to minimize eddy currents induced on the conductive pads during MR scanning. The company also performs contract research, as well as licenses its intellectual property for use in implantable devices. Imricor Medical Systems, Inc. was incorporated in 2006 and is headquartered in Burnsville, Minnesota.

The Global Cardiac Ablation Market is expected to grow by $ 1.67 bn during 2021-2025, progressing at a CAGR of 7.51% during the forecast period
August 2, 2021 | in.finance.yahoo.com

Do Insiders Own Lots Of Shares In Imricor Medical Systems, Inc. (ASX:IMR)?
July 2, 2021 | finance.yahoo.com

Electrophysiology Market Latest Research On Industry Growth, Trends, Top Players, & Key Regions By 2027
June 24, 2021 | marketwatch.com

Here's Why We're Not Too Worried About Imricor Medical Systems' (ASX:IMR) Cash Burn Situation
May 3, 2021 | finance.yahoo.com

Imricor (ASX:IMR) share price rises on latest update
May 2, 2021 | msn.com

Implantable Cardioverter-defibrillators Market - Set to Encounter Paramount 2020 – 2027
April 16, 2021 | marketwatch.com

Imricor Medical Systems, Inc.'s (ASX:IMR) Shift From Loss To Profit
March 4, 2021 | finance.yahoo.com

Maastricht Univerisity Medical Center Commences Procedures
February 24, 2021 | finance.yahoo.com

Ablation Equipment Market Analysis 2021 Analysis, Growth by Top Companies, Size, Share, Trends by Types and Application, Forecast Analysis to 2023
February 9, 2021 | marketwatch.com

Imricor Medical Systems Inc
January 22, 2021 | bloomberg.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange ASX
Industry Medical Devices
Sub-IndustryN/A
SectorMedical
Current SymbolASX:IMR
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.imricor.com
Phone952-818-8400
EmployeesN/A
Year FoundedN/A

Sales & Book Value

Annual Sales$702,161.00
Price / Sales0.00
Cash FlowN/A
Price / Cash Flow25.56
Book ValueA$0.23 per share
Price / BookN/A

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

1.00 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Imricor Medical Systems.

5.0 Community Rank

Outperform Votes
Imricor Medical Systems has received 9 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Imricor Medical Systems has received 3 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Imricor Medical Systems has received 75.00% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Imricor Medical Systems and other stocks. Vote “Outperform” if you believe IMR will outperform the S&P 500 over the long term. Vote “Underperform” if you believe IMR will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Imricor Medical Systems does not currently pay a dividend.
Dividend Growth
Imricor Medical Systems does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Imricor Medical Systems insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Imricor Medical Systems (ASX:IMR) Frequently Asked Questions

What stocks does MarketBeat like better than Imricor Medical Systems?

Wall Street analysts have given Imricor Medical Systems a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Imricor Medical Systems wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are Imricor Medical Systems' key executives?

Imricor Medical Systems' management team includes the following people:

Mr. Steve Wedan, CEO, Pres & Exec. Chairman (Age 52, Pay $565k)
Ms. Lori Milbrandt, CFO & VP of Fin.
Mr. Gregg Stenzel, Chief Operating Officer
Mr. Greg Englehardt, Exec. Director of Sales
Mr. Nick Twohy, Exec. Director of Marketing
Mr. Kobe Lizheng, Company Sec. & Local Agent

Who are some of Imricor Medical Systems' key competitors?

Some companies that are related to Imricor Medical Systems include 4DMedical (4DX), Adherium (ADR), ADM Tronics Unlimited (ADMT), Allegra Orthopaedics (AMT), Analytica (ALT), AnteoTech (ADO), Anteris Technologies (AVR), Asensus Surgical (ASXC), Atomo Diagnostics (AT1), AVITA Medical (AVH), Azure Healthcare Limited (AZV.AX) (AZV), Cannabix Technologies (BLO), CleanSpace (CSX), Cochlear (COH) and Cochlear (CHEOY).
View all of IMR's competitors.

What other stocks do shareholders of Imricor Medical Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Imricor Medical Systems investors own include Gold Standard Ventures (GSV) and Nuwellis (CHFS).

What is Imricor Medical Systems' stock symbol?

Imricor Medical Systems trades on the ASX under the ticker symbol "IMR."

How much money does Imricor Medical Systems make?

Imricor Medical Systems has a market capitalization of $0.00 and generates $702,161.00 in revenue each year.

What is Imricor Medical Systems' official website?

The official website for Imricor Medical Systems is www.imricor.com.

How can I contact Imricor Medical Systems?

The company can be reached via phone at 952-818-8400.

This page was last updated on 8/2/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.